June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Protocol for Protein Isolation from Human Orbital Fat Tissue: Use for Western Blots and Antigen Biomarker Identification in Thyroid Eye Disease
Author Affiliations & Notes
  • Katie Mills
    Ophthalmology, Hamilton Eye Institute, Memphis, TN
  • Marko Radic
    Molecular Science, University of TN, Memphis, TN
  • Indira Neeli
    Molecular Science, University of TN, Memphis, TN
  • Margaret Phillips
    Ophthalmology, Hamilton Eye Institute, Memphis, TN
  • Carolee Cutler Peck
    Ophthalmology, Hamilton Eye Institute, Memphis, TN
  • Byron Wilkes
    Ophthalmology, Hamilton Eye Institute, Memphis, TN
  • James Fleming
    Ophthalmology, Hamilton Eye Institute, Memphis, TN
  • Alessandro Iannaccone
    Ophthalmology, Hamilton Eye Institute, Memphis, TN
  • Natalie Kerr
    Ophthalmology, Hamilton Eye Institute, Memphis, TN
  • Footnotes
    Commercial Relationships Katie Mills, None; Marko Radic, None; Indira Neeli, None; Margaret Phillips, None; Carolee Cutler Peck, None; Byron Wilkes, None; James Fleming, None; Alessandro Iannaccone, None; Natalie Kerr, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5903. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Katie Mills, Marko Radic, Indira Neeli, Margaret Phillips, Carolee Cutler Peck, Byron Wilkes, James Fleming, Alessandro Iannaccone, Natalie Kerr; Protocol for Protein Isolation from Human Orbital Fat Tissue: Use for Western Blots and Antigen Biomarker Identification in Thyroid Eye Disease. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5903.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To develop a protocol for isolating proteins from orbital adipose tissue of patients with Thyroid Eye disease (TED) and unaffected controls to test the hypothesis that TED patients with increased orbital fat volume present with serum auto-Abs directed against orbital fat tissue antigens that can be used as potential disease biomarkers in TED.

 
Methods
 

Sample Collection: Human orbital fat tissue (hOFT) was harvested from 3 control subjects unaffected by TED (hOFT-CTRL) during planned eyelid and orbital surgeries in which orbital fat is routinely collected and discarded by surgeons at Hamilton Eye Institute. The orbital fat was collected from the operating room and stored in aliquots at -80οC. Phase Separation: The frozen adipose tissue was homogenized with 5mL Trizol Reagent and a Power Homogenizer. The samples were centrifuged for 10mins at 2-8οC at 12,000 xg. The top layer was discarded. The resulting liquid layer was isolated and the remaining pellet discarded. 1mL chloroform was added to the sample and centrifuged at 12,000 xg at 2-8οC for 15 minutes. The result was 3 layers, 2 liquid and one interface. The adipose tissue proteins were contained in the interface and lower layer. Acetone (3x volume of the sample) was added to the isolated interface and lower layer, mixed and centrifuged at 10,000 rpm for 10 minutes. The acetone was discarded without disturbing the resulting pellet. The pellet was washed with additional Acetone and dried. The protein pellet was mixed with 50UL 1x SDS gel loading buffer and boiled to facilitate suspension. The sample was stored at -80οC. Electrophoresis: The sample was mixed with 40uL of lysate and loading dye mix. The samples were loaded and ran for 1 hour at 35 milliAmps with a wide range BRL protein marker.

 
Results
 

By following this protocol, hOFT proteins were successfully isolated from hOFT intraoperative samples with little apparent degradation.

 
Conclusions
 

With a successful protein isolation protocol, Western Blots to test for presence of auto-antibodies against orbital fat tissue antigens can be performed. The comprehensive analysis of the orbital fat tissue proteome from TED and control individuals and the identification of autoantibodies from patients and controls will provide testable hypotheses to explore TED pathogenesis.

  
Keywords: 432 autoimmune disease • 631 orbit • 658 protein purification and characterization  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×